• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Friday, June 11, 2021

    Time

    10:30 AM - 11:30 AM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1 Contact Hour(s)

    Target Audience

    Pharmacist, Nurse

    Cost

    $0.00

    • Overview

      Nearly 50 million people worldwide live with dementia, and of those, up to 90% will experience Behavioral and Psychological Symptoms of Dementia (BPSD), including psychosis, during their disease progression. Psychotic symptoms of dementia include hallucinations, delusions, and delusional misidentifications. These symptoms decrease patients’ quality of life and are often distressing for patients and caregivers. Management of psychosis in dementia can be challenging and requires a comprehensive pharmacologic and non-pharmacologic approach. Pharmacologic management is complicated by a lack of approved medications for this indication and marked by low efficacy and high risk of adverse effects for the agents normally employed. This educational activity will educate pharmacists and nurses on the types and causes of dementia-related psychosis (DRP) and how to recognize DRP in the older adult population. This activity will educate pharmacists and nurses on the proper use of treatments for DRP, with a focus on the long-term care setting. This activity will also include discussion on emerging treatments for DRP, as this remains an area of high need. Clinical data about agents currently being studied for DRP will be presented and discussed to give learners the most up-to-date view of the treatment landscape.


      Handouts

      Slide Document 21029L01_2pp.pdf
      Slide Document 21029L01_6pp.pdf





      Financial Support By

      Acadia Pharmaceuticals, Inc.
    • Pharmacist

      Differentiate between types and causes of dementia-related psychosis (DRP).
      Compare and contrast treatments for DRP, including non-pharmacological and current pharmacological treatments.
      Examine clinical data for agents being studied for the treatment of DRP.

      Nurse

      Differentiate between types and causes of dementia-related psychosis (DRP).
      Compare and contrast treatments for DRP, including non-pharmacological and current pharmacological treatments.
      Examine clinical data for agents being studied for the treatment of DRP.
    • Repeat Presentation

      This presentation was last given on 6/11/2021 10:30 AM

      Future Airings

      Date Time
      Monday, June 21, 2021 8:00 PM View
      Saturday, July 10, 2021 11:30 AM View
      Friday, August 6, 2021 10:30 AM View

    • Activity Type

      Application

      CE Broker

      20-770213

      Universal Activity Number

      Pharmacist 0798-0000-21-029-L01-P

      Nurse 0798-0000-21-029-L01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.